Filing Details
- Accession Number:
- 0001209191-16-138658
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-25 16:49:07
- Reporting Period:
- 2016-08-24
- Filing Date:
- 2016-08-25
- Accepted Time:
- 2016-08-25 16:49:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1326732 | Xencor Inc | XNCR | Pharmaceutical Preparations (2834) | 201622502 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1591306 | J John Kuch | C/O Xencor, Inc. 111 West Lemon Avenue Monrovia CA 91016 | Vice President, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-08-24 | 14,350 | $11.05 | 92,078 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-08-24 | 16,405 | $21.76 | 75,673 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-08-24 | 8,595 | $22.32 | 67,078 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2016-08-24 | 14,350 | $0.00 | 14,350 | $11.05 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 55,650 | 2024-02-20 | No | 4 | M | Direct |
Footnotes
- The weighted average sale price for the transaction reported was $21.76, and the range of prices were between $21.11 and $22.075. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $22.32, and the range of prices were between $22.25 and $22.35. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- 25% of the shares subject to the option shall vest on the one year anniversary of February 21, 2014 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest monthly thereafter, such that the option shall be fully vested on the four year anniversary of the Vesting Commencement Date.
Billionaire Hedge Funds
